Why insider trading matters?

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

- Peter Lynch
Axogen, Inc. (AXGN)
Sector: Healthcare; Industry: Medical Devices

AxoGen, Inc., together with its subsidiaries, provides surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. AxoGen, Inc. is headquartered in Alachua, Florida.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-02-25 Freitag Gregory Gene Director Sell 24,000 $22.06 $529,440 No
2021-02-18 Donovan Michael Patrick VP Operations Sell 1,808 $19.15 $34,623 No
2021-01-08 Zaderej Karen L. CEO Sell 65,000 $20.00 $1,300,000 No
2020-12-30 Donovan Michael Patrick VP Operations Sell 1,733 $17.48 $30,293 No
2020-12-29 DeVinney Erick Wayne VP, Clinical&Translational Sc Sell 371 $17.81 $6,608 No
2020-12-29 Donovan Michael Patrick VP Operations Sell 567 $17.81 $10,098 No
2020-12-29 Freitag Gregory Gene Director Sell 916 $17.81 $16,314 No
2020-12-29 MARIANI PETER J Chief Financial Officer Sell 1,293 $17.81 $23,028 No
2020-12-29 Scopelianos Angelo VP Research & Development Sell 567 $17.81 $10,098 No
2020-12-29 Zaderej Karen L. CEO Sell 3,500 $17.81 $62,335 No
2020-12-29 Friedman Mark Louis VP, Regulatory & Quality Sell 567 $17.81 $10,098 No
2020-12-29 MARTINEZ MARIA D. Chief Human Resources Officer Sell 567 $17.81 $10,098 No
2020-12-29 Billet Isabelle Chief Strategy and BD Officer Sell 649 $17.81 $11,559 No
2020-12-22 Donovan Michael Patrick VP Operations Sell 279 $17.19 $4,796 No
2020-12-21 Zaderej Karen L. CEO Sell 1,275 $16.42 $20,936 No
2020-12-21 DeVinney Erick Wayne VP, Clinical&Translational Sc Sell 147 $16.42 $2,414 No
2020-12-21 Freitag Gregory Gene Director Sell 379 $16.42 $6,223 No
2020-12-21 Donovan Michael Patrick VP Operations Sell 96 $16.42 $1,576 No
2020-12-21 MARIANI PETER J Chief Financial Officer Sell 481 $16.42 $7,898 No
2020-12-21 Friedman Mark Louis VP, Regulatory & Quality Sell 96 $16.42 $1,576 No
2020-11-09 Donovan Michael Patrick VP Operations Sell 17,617 $15.00 $264,255 No
2020-11-09 Zaderej Karen L. CEO Sell 14,000 $14.53 $203,420 No
2020-10-30 MARIANI PETER J Chief Financial Officer Sell 75,683 $12.41 $939,353 Yes
2019-08-12 Blackford Quentin S. Director Buy 15,535 $14.01 $217,672 No
2019-08-09 Gold Mark Stephen Director Buy 4,000 $13.10 $52,389 No
2019-08-13 Billet Isabelle Chief Strategy and BD Officer Buy 5,635 $15.11 $85,139 No
2019-08-14 MARTINEZ MARIA D. Chief Human Resources Officer Buy 2,000 $15.13 $30,260 No
2019-08-12 Blackford Quentin S. Director Buy 15,535 $14.01 $217,672 No
2019-08-09 Zaderej Karen L. CEO Buy 75,000 $13.50 $1,012,425 No
2019-06-13 Donovan Michael Patrick VP Operations Sell 20,000 $20.00 $400,000 No

Insider Smart

Enphase Energy, Inc (ENPH) - ENPH was $10+ in 15Q1 then dropped to $2 and eventually went under $1. From 15Q4 to 17Q4 it built a 2-year-long base then BOOM! Stock went as high as $70 and likely will make a new high. Catch one or two moves like this you can retire early. One hint before the big move was that CEO and CFO were constantly accumulating, this kind of information is priceless.